[FG] Trendelenburg Marten

Erne, Livio et al. (2025) ‘Acute dose-dependent effects and self-guided titration of continuous N,N-dimethyltryptamine infusions in a double-blind placebo-controlled study in healthy participants’, Neuropsychopharmacology, 50(6), pp. 1008–1016. Available at: https://doi.org/10.1038/s41386-024-02041-8.

Dräger, Sarah et al. (2025) ‘Target attainment of beta-lactam antibiotics and ciprofloxacin in critically ill patients and its association with 28-day mortality’, Journal of Critical Care. 14.09.2024, 85. Available at: https://doi.org/10.1016/j.jcrc.2024.154904.

Oechtering, Johanna et al. (2025) ‘Aberrant Complement Activation Is Associated With Structural Brain Damage in Multiple Sclerosis’, Neurology: Neuroimmunology and NeuroInflammation, 12(2). Available at: https://doi.org/10.1212/NXI.0000000000200361.

Boesing, Maria et al. (2024) ‘Impfung von erwachsenen Patienten mit chronischen Lungenerkrankungen’, Praxis, 113(11/12), pp. 297–305. Available at: https://doi.org/10.23785/PRAXIS.2024.11.003.

Kruta, Jan et al. (2024) ‘Machine learning for precision diagnostics of autoimmunity’, Scientific Reports, 14(1). Available at: https://doi.org/10.1038/s41598-024-76093-7.

Michael Osthoff and Andrea Erba (2024) ‘Less is more: advanced diagnostic tests and smarter algorithms are urgently needed in encephalitis with absent CSF pleocytosis’. Available at: https://doi.org/10.1093/cid/ciae567.

Jost, Lorena et al. (2024) ‘A Case of Hypocomplementemic Urticarial Vasculitis Syndrome With Severe Renal and Gastrointestinal Involvement’, Cureus, 16(10). Available at: https://doi.org/10.7759/cureus.72113.

Blickenstorfer, Yves et al. (2024) ‘Iodide based electrochemical gold quantification method for lateral flow assays’, Biosensors and Bioelectronics. 15.10.2024, 262. Available at: https://doi.org/10.1016/j.bios.2024.116524.

Bausch, Severin et al. (2024) ‘Target Attainment and Population Pharmacokinetics of Cefazolin in Patients with Invasive Staphylococcus aureus Infections: A Prospective Cohort Study’, Antibiotics, 13(10), p. 928. Available at: https://doi.org/10.3390/antibiotics13100928.

Moser, Stephan et al. (2024) ‘Association of Endothelial Cell Activation with Acute Kidney Injury during Coronary Angiography and the Influence of Recombinant Human C1 Inhibitor—A Secondary Analysis of a Randomized, Placebo-Controlled, Double-Blind Trial’, Biomedicines, 12(9). Available at: https://doi.org/10.3390/biomedicines12091956.

Müller, Sereina Livia et al. (2024) ‘Misdiagnosed Antibiotic-Induced Liver Injury: Unveiling Acute Hepatitis E in a 65-Year-Old Patient’, American Journal of Case Reports . 17.07.2024, 25. Available at: https://doi.org/10.12659/AJCR.944508.

Eckardt, Henrik et al. (2024) ‘Major low-energy trauma results in non-specific immunoglobulin generation without evidence for specific autoantibody production: A prospective cohort study’, Scandinavian Journal of Immunology, 99. Available at: https://doi.org/10.1111/sji.13368.

Isayeva, Ganna et al. (2024) ‘Diagnostic and prognostic value of mannan-binding lectin associated protein (MAp19) for functionally relevant coronary artery disease’, Clinica Chimica Acta, 558. Available at: https://doi.org/10.1016/j.cca.2024.119668.

Couchepin, Jade et al. (2024) ‘Isavuconazole for the Treatment of Fungal Infections: A Real-life Experience From the Fungal Infection Network of Switzerland (FUNGINOS)’, Open Forum Infectious Diseases, 11(5). Available at: https://doi.org/10.1093/ofid/ofae223.

Thomann, Jan et al. (2024) ‘Development and validation of an LC-MS/MS method for quantifying diamorphine and its major metabolites 6-monoacetylmorphine, morphine, morphine-3-glucuronide, and morphine-6-glucuronide in human plasma’, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 1237, p. 124104. Available at: https://doi.org/10.1016/j.jchromb.2024.124104.

Dräger, Sarah et al. (2024) ‘Impact of Swabbing Location, Self-Swabbing, and Food Intake on SARS-CoV-2 RNA Detection’, Microorganisms, 12(3). Available at: https://doi.org/10.3390/microorganisms12030591.

Oechtering, Johanna et al. (2024) ‘Complement Activation Is Associated With Disease Severity in Multiple Sclerosis’, Neurology: Neuroimmunology and NeuroInflammation, 11(2). Available at: https://doi.org/10.1212/NXI.0000000000200212.

Erba, Andrea et al. (2024) ‘Utilization of a Meningitis/Encephalitis PCR panel at the University Hospital Basel – a retrospective study to develop a diagnostic decision rule’, Frontiers in Medicine, 11. Available at: https://doi.org/10.3389/fmed.2024.1351903.

Kleer, Jessica S. et al. (2024) ‘Factor H-related protein 1 in systemic lupus erythematosus’, Frontiers in Immunology, 15. Available at: https://doi.org/10.3389/fimmu.2024.1447991.

Waters, Mitchell L. et al. (2024) ‘Clinical effects of cannabis compared to synthetic cannabinoid receptor agonists (SCRAs): a retrospective cohort study of presentations with acute toxicity to European hospitals between 2013 and 2020’, Clinical Toxicology, 62(6), pp. 378–384. Available at: https://doi.org/10.1080/15563650.2024.2346125.

Agnetti, Jessica et al. (2023) ‘Identification of microorganisms by a rapid PCR panel from positive blood cultures leads to faster optimal antimicrobial therapy – a before-after study’, BMC Infectious Diseases, 23(1). Available at: https://doi.org/10.1186/s12879-023-08732-9.

Etienne, Samuel et al. (2023) ‘Free-living core body temperature monitoring using a wrist-worn sensor after COVID-19 booster vaccination: a pilot study’, BioMedical Engineering Online, 22(1). Available at: https://doi.org/10.1186/s12938-023-01081-3.

Mihailovic, Jelena et al. (2023) ‘Worse cardiovascular and renal outcome in male SLE patients’, Scientific Reports, 13(1). Available at: https://doi.org/10.1038/s41598-023-45171-7.

Vogt, Severin B. et al. (2023) ‘Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants’, Translational Psychiatry, 13(1). Available at: https://doi.org/10.1038/s41398-023-02477-4.

Isayeva, Ganna et al. (2023) ‘Diagnostic and prognostic value of H-ficolin for functionally relevant coronary artery disease’, Clinica Chimica Acta, 551. Available at: https://doi.org/10.1016/j.cca.2023.117582.

Gross, Sebastian et al. (2023) ‘Occurrence of sensitive topics during ward round: An ancillary analysis of the BEDSIDE-OUTSIDE trial’, BMJ Open, 13(9). Available at: https://doi.org/10.1136/bmjopen-2023-073584.

Breillat P et al. (2023) ‘Cutaneous vasculitis occurring in the setting of systemic lupus erythematosus: a multicentre cohort study’, Rheumatology (United Kingdom), 62(6), pp. 2189–2196. Available at: https://doi.org/10.1093/rheumatology/keac566.

Lopez-Morales, J. et al. (2023) Rapidly Adaptable Multiplexed Yeast Surface Display Serological Assay for Immune Escape Screening of SARS-CoV-2 Variants. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2023.02.17.23286074.

Etienne S et al. (2023) ‘Prevention of Hepatitis B Reactivation in Patients Receiving Immunosuppressive Therapy: a Case Series and Appraisal of Society Guidelines’, Journal of General Internal Medicine, 38(2), pp. 490–501. Available at: https://doi.org/10.1007/s11606-022-07806-9.

Isayeva, Anna et al. (2023) ‘Diagnostic and Prognostic Value of H-ficolin and Mannose-Binding Lectin for Functionally Relevant Coronary Artery Disease’, in Swiss Medicalf Weekly. Basel: SMW supporting association (SGAIM Frühjahrskongress), pp. 110S–110S.

Kleer, Jessica S. et al. (2023) ‘Complement C1s deficiency in a male Caucasian patient with systemic lupus erythematosus: a case report’, Frontiers in Immunology, 14. Available at: https://doi.org/10.3389/fimmu.2023.1257525.

Rabatscher, P. (2023) Immunological consequences of C1q and anti-c1q immune complexes in secondary cellular inflammation. Doctoral Thesis.

Schulz, Kristina et al. (2023) ‘Complement C1q and von Willebrand factor interaction in atherosclerosis of human carotid artery’, Frontiers in Immunology, 14. Available at: https://doi.org/10.3389/fimmu.2023.1265387.

Schulz, Kristina et al. (2023) ‘Complement C1q and von Willebrand factor interaction in atherosclerosis of human carotid artery’, Frontiers in Immunology, 14. Available at: https://doi.org/10.3389/fimmu.2023.1265387.

Urwyler, Pascal et al. (2023) ‘Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial’, Frontiers in Immunology, 14. Available at: https://doi.org/10.3389/fimmu.2023.1255292.

Luethi, Dino et al. (2022) ‘Liquid chromatography–tandem mass spectrometry method for the bioanalysis of N,N-dimethyltryptamine (DMT) and its metabolites DMT-N-oxide and indole-3-acetic acid in human plasma’, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 1213. Available at: https://doi.org/10.1016/j.jchromb.2022.123534.

Vallapurackal, Jaicy et al. (2022) ‘Ultrahigh-Throughput Screening of an Artificial Metalloenzyme using Double Emulsions**’, Angewandte Chemie - International Edition, 61(48). Available at: https://doi.org/10.1002/anie.202207328.

Gürtler N et al. (2022) ‘Nosocomial human parainfluenza virus type 3 outbreak in immunocompromised patients, and possible lessons from the SARS-CoV-2 pandemic’, Journal of Hospital Infection. W.B. Saunders Ltd, 129. Available at: https://doi.org/10.1016/j.jhin.2022.07.002.

Urwyler, Pascal et al. (2022) ‘Targeting thromboinflammation in COVID-19 – A narrative review of the potential of C1 inhibitor to prevent disease progression’, Molecular Immunology, 150, pp. 99–113. Available at: https://doi.org/10.1016/j.molimm.2022.08.008.

Bruni F et al. (2022) ‘Complement and endothelial cell activation in COVID-19 patients compared to controls with suspected SARS-CoV-2 infection: A prospective cohort study’, Frontiers in Immunology, 13, p. 941742. Available at: https://doi.org/10.3389/fimmu.2022.941742.

Darie, Andrei M et al. (2022) ‘Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial’, The Lancet Respiratory Medicine, 10(9), pp. 877–887. Available at: https://doi.org/10.1016/S2213-2600(22)00086-8.

Schulz K. and Trendelenburg M. (2022) ‘C1q as a target molecule to treat human disease: What do mouse studies teach us?’, Frontiers in Immunology, 13. Available at: https://doi.org/10.3389/fimmu.2022.958273.

Capoferri G et al. (2022) ‘Cutaneous leukocytoclastic vasculitis secondary to COVID-19 infection leading to extensive skin necrosis’, Clinics in Dermatology, 40(4), pp. 397–401. Available at: https://doi.org/10.1016/j.clindermatol.2022.02.013.

Costa A.E. et al. (2022) ‘Severe myopathy complicating multisystem inflammatory syndrome in adults (MIS-A) in a young man’, BMJ Case Reports, 15(7). Available at: https://doi.org/10.1136/bcr-2022-250054.

Etienne S et al. (2022) ‘Challenges of Primary Care Medicine in a Tertiary Care Setting—The Case of Primary CMV Infection Compared to Primary EBV Infection: A Retrospective Cohort Study’, Frontiers in Medicine, 9, p. 880610. Available at: https://doi.org/10.3389/fmed.2022.880610.

Bausch S et al. (2022) ‘Cefepime-Induced Neurotoxicity in the Setting of Acute Kidney Injury: A Case Series and Discussion of Preventive Measures.’, 14(6). Available at: https://doi.org/10.7759/cureus.26392.

Bassetti S et al. (2022) ‘Optimizing antibiotic therapies to reduce the risk of bacterial resistance’, European Journal of Internal Medicine, 99, pp. 7–12. Available at: https://doi.org/10.1016/j.ejim.2022.01.029.

Huebner, Simona Tabea et al. (2022) ‘Prediction of Acute COPD Exacerbation in the Swiss Multicenter COPD Cohort Study (TOPDOCS) by Clinical Parameters, Medication Use, and Immunological Biomarkers’, Respiration, 101(5), pp. 441–454. Available at: https://doi.org/10.1159/000520196.

Gross S. et al. (2022) ‘Perception of physicians and nursing staff members regarding outside versus bedside ward rounds: Ancillary analysis of the randomised BEDSIDE-OUTSIDE trial’, Swiss Medical Weekly, 152(3-4). Available at: https://doi.org/10.4414/smw.2022.w30112.

Kleer JS et al. (2022) ‘Epitope-Specific Anti-C1q Autoantibodies in Systemic Lupus Erythematosus’, Frontiers in Immunology, 12, p. 761395. Available at: https://doi.org/10.3389/fimmu.2021.761395.

Chasset F. et al. (2022) ‘Serum interferon-α levels and IFN type I-stimulated genes score perform equally to assess systemic lupus erythematosus disease activity’, Annals of the Rheumatic Diseases, 81(6), pp. 901–903. Available at: https://doi.org/10.1136/annrheumdis-2021-221835.

Potlukova, Eliska et al. (2022) ‘First-year medical students at the patient bed – early clinical exposure through a project-based learning tool in internal medicine’, in AMEE 2022 – Lyon, France. Lyon, France (AMEE 2022 – Lyon, France), p. Abstract ID: 3679.

Rabatscher P.A. and Trendelenburg M. (2022) ‘Anti-C1q autoantibodies from systemic lupus erythematosus patients enhance CD40–CD154-mediated inflammation in peripheral blood mononuclear cells in vitro’, Clinical and Translational Immunology, 11(8). Available at: https://doi.org/10.1002/cti2.1408.

Rumo, Corentin et al. (2022) ‘An Artificial Metalloenzyme Based on a Copper Heteroscorpionate Enables sp³ C-H Functionalization via Intramolecular Carbene Insertion’, Journal of the American Chemical Society, 144(26), pp. 11676–11684. Available at: https://doi.org/10.1021/jacs.2c03311.

Schmid Y et al. (2022) ‘Differences in clinical features associated with cannabis intoxication in presentations to European emergency departments according to patient age and sex’, Clinical Toxicology, 60(8), pp. 912–919. Available at: https://doi.org/10.1080/15563650.2022.2060116.

Seelmann,Sonja et al. (2022) ‘First-year medical students at the patient bed – early clinical exposure through a project-based learning tool in internal medicine’, in SGAIM Frühjahrskongress. Lausanne: sgaim.ch (SGAIM Frühjahrskongress).

Weis C et al. (2022) ‘Direct antimicrobial resistance prediction from clinical MALDI-TOF mass spectra using machine learning’, Nature Medicine, 28(1), pp. 164–174. Available at: https://doi.org/10.1038/s41591-021-01619-9.

Søgaard KK et al. (2021) ‘Community-acquired and hospital-acquired respiratory tract infection and bloodstream infection in patients hospitalized with COVID-19 pneumonia’, Journal of Intensive Care, 9(1), p. 10. Available at: https://doi.org/10.1186/s40560-021-00526-y.

Urwyler, Pascal et al. (2021) ‘Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)’, Trials, 22(1). Available at: https://doi.org/10.1186/s13063-020-04976-x.

Vogt S et al. (2021) ‘Association of mannose-binding lectin, ficolin-2 and immunoglobulin concentrations with future exacerbations in patients with chronic obstructive pulmonary disease: secondary analysis of the randomized controlled REDUCE trial’, Respiratory Research, 22(1), p. 227. Available at: https://doi.org/10.1186/s12931-021-01822-9.

Charitos P. et al. (2021) ‘Functional Activity of the Complement System in Hospitalized COVID-19 Patients: A Prospective Cohort Study’, Frontiers in Immunology, 12. Available at: https://doi.org/10.3389/fimmu.2021.765330.

Adam KM et al. (2021) ‘Trends of the epidemiology of Candidemia in Switzerland: A 15-year FUNGINOS survey’, Open Forum Infectious Diseases, 8(10), p. ofab471. Available at: https://doi.org/10.1093/ofid/ofab471.

Becker C et al. (2021) ‘Effect of bedside compared with outside the room patient case presentation on patients” knowledge about their medical care: A randomized, controlled, multicenter trial’, Annals of Internal Medicine, 174(9), pp. 1282–1292. Available at: https://doi.org/10.7326/M21-0909.

Kiener S. et al. (2021) ‘Variants affecting the C-terminal tail of UNC93B1 are not a common risk factor for systemic lupus erythematosus’, Genes, 12(8). Available at: https://doi.org/10.3390/genes12081268.

Diebold M et al. (2021) ‘Temporal trends of COVID-19 related in-hospital mortality and demographics in Switzerland - a retrospective single centre cohort study’, Swiss Medical Weekly, 151(29-30), p. w20572. Available at: https://doi.org/10.4414/smw.2021.20572.

Mihailovic, J. et al. (2021) ‘Worse Cardiovascular and Renal Outcome in Male SLE Patients: First Gender Study From the Swiss SLE Cohort Study’. Research Square Platform LLC. Available at: https://doi.org/10.21203/rs.3.rs-645732/v1.

Moser S. et al. (2021) ‘Probability of pharmacological target attainment with flucloxacillin in Staphylococcus aureus bloodstream infection: A prospective cohort study of unbound plasma and individual MICs’, Journal of Antimicrobial Chemotherapy, 76(7), pp. 1845–1854. Available at: https://doi.org/10.1093/jac/dkab089.

Brasier, Noé et al. (2021) ‘Digital biomarkers from sweat analysis for therapeutic drug monitoring in soft tissue infections’. Association for Computing Machinery, Inc, pp. 45–50. Available at: https://doi.org/10.1145/3469266.3471179.

Leuzinger K et al. (2021) ‘Epidemiology and precision of SARS-CoV-2 detection following lockdown and relaxation measures’, Journal of Medical Virology, 93(4), pp. 2374–2384. Available at: https://doi.org/10.1002/jmv.26731.

Capoferri G et al. (2021) ‘Relative bradycardia in patients with COVID-19’, Clinical Microbiology and Infection. Elsevier B.V., 27(2). Available at: https://doi.org/10.1016/j.cmi.2020.08.013.

Bertschi, Jasmin (2021) The impact of monocytes on CD3/D28 activated T cells upon anti-C1q autoantibody encounter. Masterarbeit.

Brasier, Noé et al. (2021) ‘Next-Generation Digital Biomarkers for Tuberculosis and Antibiotic Stewardship: Perspective on Novel Molecular Digital Biomarkers in Sweat, Saliva, and Exhaled Breath’, Journal of Medical Internet Research, 23(8), p. e25907. Available at: https://doi.org/10.2196/25907.

Brasier N et al. (2021) ‘The Detection of Vancomycin in Sweat: A Next-Generation Digital Surrogate Marker for Antibiotic Tissue Penetration: A Pilot Study’, Digital Biomarkers, 5(1), pp. 24–28. Available at: https://doi.org/10.1159/000512947.

Csorba K. et al. (2021) ‘Anti-C1q Autoantibodies: Standard Quantification and Innovative ELISA’, in Methods in Molecular Biology. Humana Press Inc. (Methods in Molecular Biology), pp. 107–114. Available at: https://doi.org/10.1007/978-1-0716-1016-9_10.

Jautz J et al. (2021) ‘More than meets the eye: Bacteremic pneumococcal pneumonia as the initial presentation of multiple myeloma’, American Journal of Case Reports, 22(1), pp. 1–4. Available at: https://doi.org/10.12659/AJCR.927904.

Mari, Alfredo et al. (2021) ‘Global Genomic Analysis of SARS-CoV-2 RNA Dependent RNA Polymerase Evolution and Antiviral Drug Resistance’, Microorganisms, 9(5), p. 1094. Available at: https://doi.org/10.3390/microorganisms9051094.

Merlo P, Rochlitz C and Osthoff M (2021) ‘The Alkaline Phosphatase Flare Phenomenon: A Transient Substantial Increase in Alkaline Phosphatase Concentration in a Prostate Cancer Patient after Starting GnRH Agonist Treatment’, Case Reports in Oncology. S. Karger AG, 14(1). Available at: https://doi.org/10.1159/000513427.

Stange, Madlen et al. (2021) ‘SARS-CoV-2 outbreak in a tri-national urban area is dominated by a B.1 lineage variant linked to a mass gathering event’, PLoS Pathogens, 17(3), p. ARTN e1009374. Available at: https://doi.org/10.1371/journal.ppat.1009374.

Trendelenburg M. (2021) ‘Autoantibodies against complement component C1q in systemic lupus erythematosus’, Clinical and Translational Immunology, 10(4). Available at: https://doi.org/10.1002/cti2.1279.

Kieninger-Gräfitsch A et al. (2020) ‘No association of complement mannose-binding lectin deficiency with cardiovascular disease in patients with Systemic Lupus Erythematosus’, Scientific Reports, 10(1), p. 3693. Available at: https://doi.org/10.1038/s41598-020-60523-3.

Brasier, N. et al. (2020) Next-Generation Digital Biomarkers for Tuberculosis and Antibiotic Stewardship: Perspective on Novel Molecular Digital Biomarkers in Sweat, Saliva, and Exhaled Breath (Preprint). JMIR Publications Inc. Available at: https://doi.org/10.2196/preprints.25907.

Chasset F et al. (2020) ‘Identification of highly active systemic lupus erythematosus by combined type I interferon and neutrophil gene scores vs classical serologic markers’, Rheumatology (United Kingdom), 59(11), pp. 3468–3478. Available at: https://doi.org/10.1093/rheumatology/keaa167.

Strasser DS et al. (2020) ‘Preclinical to clinical translation of cenerimod, a novel S1P 1 receptor modulator, in systemic lupus erythematosus’, RMD Open, 6(2). Available at: https://doi.org/10.1136/rmdopen-2020-001261.

Häfelfinger, Romina et al. (2020) ‘Simultaneous VZV and HSV-1 reactivation after minor head injury’, European Journal of Case Reports in Internal Medicine, 7(12). Available at: https://doi.org/10.12890/2020_001746.

Urwyler, Pascal et al. (2020) ‘Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System’, Frontiers in Immunology, 11. Available at: https://doi.org/10.3389/fimmu.2020.02072.

Weis, C. et al. (2020) Direct Antimicrobial Resistance Prediction from clinical MALDI-TOF mass spectra using Machine Learning. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2020.07.30.228411.

Donat C et al. (2020) ‘Complement C1q Enhances Primary Hemostasis’, Frontiers in Immunology, 11, p. 1522. Available at: https://doi.org/10.3389/fimmu.2020.01522.

Sarcevic J et al. (2020) ‘Case Report—Secondary Antibody Deficiency Due to Endogenous Hypercortisolism’, Frontiers in Immunology. Frontiers Media S.A., 11. Available at: https://doi.org/10.3389/fimmu.2020.01435.

Schunemann M.J. et al. (2020) ‘Wither Away: Weight Loss and Persistent Inflammation in a Woman With Whipple Disease’, American Journal of Medicine, 133(6), pp. e223–e226. Available at: https://doi.org/10.1016/j.amjmed.2019.08.058.

Gürtler N et al. (2020) ‘[Hematochezia and right-sided upper abdominal pain after puncture of a liver abscess in a 75-year-old male].’, Der Internist, 61(5), pp. 513–517. Available at: https://doi.org/10.1007/s00108-020-00781-5.

Panagiotou A et al. (2020) ‘A Randomized Trial of Recombinant Human C1-Esterase-Inhibitor in the Prevention of Contrast-Induced Kidney Injury’, JACC: Cardiovascular Interventions, 13(7), pp. 833–842. Available at: https://doi.org/10.1016/j.jcin.2019.11.021.

Erba A et al. (2020) ‘OPAT in Switzerland: single-center experience of a model to treat complicated infections’, Infection, 48(2), pp. 231–240. Available at: https://doi.org/10.1007/s15010-019-01381-8.

Nigolian H et al. (2020) ‘Anti-apolipoprotein A-1 autoantibodies correlate with disease activity in systemic lupus erythematosus’, Rheumatology (United Kingdom), 59(3), pp. 534–544. Available at: https://doi.org/10.1093/rheumatology/kez306.

Brasier, Noé et al. (2020) ‘Non-invasive Drug Monitoring of β-Lactam Antibiotics Using Sweat Analysis-A Pilot Study’, Frontiers in Medicine, 7(476). Available at: https://doi.org/10.3389/fmed.2020.00476.

Diebold M, Kuster S and Osthoff M (2020) ‘Reversible Hippocratic Fingers in a Patient with Pneumonia’, American Journal of Medicine, 133(1), pp. e9–e10. Available at: https://doi.org/10.1016/j.amjmed.2019.07.010.

Donat, C. (2020) Immunological and functional consequences of von Willebrand factor binding to complement C1q. Doctoral Thesis. Available at: https://doi.org/10.5451/unibas-007198268.

Juliane Klehr, Jingming Zhao, Amanda Santos Kron, Thomas R. Ward & Valentin Köhler (2020) ‘Streptavidin (Sav)-Based Artificial Metalloenzymes: Cofactor Design Considerations and Large-Scale Expression of Host Protein Variants’, in Peptide and Protein Engineering. (Peptide and Protein Engineering).

Marzolini, Catia et al. (2020) ‘Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations’, Antimicrobial Agents and Chemotherapy, 64(9), pp. e01177–20. Available at: https://doi.org/10.1128/aac.01177-20.

Rabes, Clemens et al. (2020) ‘Zwischen Traum und Trauma - Aufbau und Betrieb einer Kohortenstation für Patient_innen mit COVID-19 in einem Akutspital’, Pflege, 33(4), pp. 247–255. Available at: https://doi.org/10.1024/1012-5302/a000746.

Sarcevic, Jelena et al. (2020) ‘Secondary Antibody Deficiency Due to Endogenous Hypercortisolism’, Frontiers in Immunology, 11, p. 1435. Available at: https://doi.org/10.3389/fimmu.2020.01435.